@article{6186d104fd704dd6bc900ee06791aa0a,
title = "Survival and causes of death in 2,033 patients with non-transfusion-dependent β-thalassemia",
author = "{International Working Group on Thalassemia (IWG-THAL)} and Musallam, {Khaled M.} and Angela Vitrano and Antonella Meloni and Pollina, {Sebastiano Addario} and Mehran Karimi and Amal El-Beshlawy and Mahmoud Hajipour and Marco, {Vito Di} and Ansari, {Saqib Hussain} and Aldo Filosa and Paolo Ricchi and Adriana Ceci and Shahina Daar and Efthymia Vlachaki and Singer, {Sylvia Titi} and Naserullah, {Zaki A.} and Alessia Pepe and Salvatore Scondotto and Gabriella Dardanoni and Fedele Bonifazi and Sankaran, {Vijay G.} and Elliott Vichinsky and Taher, {Ali T.} and Aurelio Maggio",
note = "Funding Information: Pharmaceutical Industry and Novartis; ATT has been or is a consultant for Novartis, Celgene Corp (Bristol Myers Squibb), Vifor Pharma, Silence Therapeutics and Ionis Pharmaceuticals; and received research funding from Novartis, Celgene Corp (Bristol Myers Squibb), La Jolla Pharmaceutical Company, Roche, Protagonist Therapeutics and Agios Pharmaceuticals; AM has been or is a member of advisory boards for Novartis, Celgene Corp (Bristol Meyers Squibb) and Bluebird Bio. The remaining authors have no conflicts of interest to disclose.",
year = "2021",
month = sep,
doi = "10.3324/haematol.2021.278684",
language = "English",
volume = "106",
pages = "2489--2492",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "9",
}